Yeah, that's true. And a company can count on an expense of 100-300 million to jump through the FDA hoops for approval.
At least, according to the companies. And I'm a bit curious about how much review and confirmation of the data presented by the company actually is done by the FDA.
The $2-3M to which I referred was just to get the process started and to the point where you basically drop off the drug at the FDA's doorstep. I did not mention the additional monies needed to get everything to the point where the FDA grants approval.
